Miodrag Janic
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Is incretin therapy the missing link to silencing residual inflammation in biologic-treated psoriasis?
Journal: Expert opinion on biological therapy
Published: August 12, 2026
Tirzepatide data: safety first is safety always!
Journal: Expert opinion on drug safety
Published: May 27, 2026
Psychological distress in young adults with well-controlled psoriasis.
Journal: Frontiers in psychiatry
Published: November 24, 2025
IL-6 as an integrative biomarker of residual inflammation and visceral adiposity in psoriasis: a VAI threshold-dependent model.
Journal: Frontiers in immunology
Published: September 04, 2025
Reduced Fibrinolysis Links Obesity to Cardiovascular Risk in Psoriasis Independently of Inflammation: A Novel Mechanistic Pathway.
Journal: Acta dermato-venereologica
Published: August 30, 2025
Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota.
Journal: Therapeutics and clinical risk management
Published: May 15, 2025
Overall hemostatic potential as a marker of subclinical hypercoagulability in treated psoriasis patients.
Journal: Frontiers in medicine
Published: April 14, 2025
Machine learning and deep learning in diabetology: revolutionizing diabetes care.
Journal: Frontiers in clinical diabetes and healthcare
Published: December 18, 2024
Rosuvastatin Improved LDL Subfractions Profile in a Patient with Type 1 Diabetes Following a Ketogenic Diet: A Case Report.
Journal: Current vascular pharmacology
Published: November 12, 2024
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Journal: Medicina (Kaunas, Lithuania)
Published: November 11, 2024
Last Updated: 09/26/2026